HUE047263T2 - Staphylococcus aureus antigének stabil immunogén készítményei - Google Patents

Staphylococcus aureus antigének stabil immunogén készítményei

Info

Publication number: HUE047263T2
Authority: HU; Hungary
Prior art keywords: staphylococcus aureus; immunogenic compositions; aureus antigens; stable immunogenic; stable
Prior art date: 2010-12-22

Application number

HUE16193095A

Other languages

English (en)

Inventor

Lakshmi Khandke

Akihisa Nonoyama

Tamara Shafer Hodge

Sandeep Nema

Original Assignee

Wyeth Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-12-22

Filing date

2011-12-21

Publication date

2020-04-28

2011-12-21 Application filed by Wyeth Llc filed Critical Wyeth Llc

2020-04-28 Publication of HUE047263T2 publication Critical patent/HUE047263T2/hu

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)

HUE16193095A 2010-12-22 2011-12-21 Staphylococcus aureus antigének stabil immunogén készítményei HUE047263T2 (hu)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201061426476P	2010-12-22	2010-12-22

Publications (1)

Publication Number	Publication Date
HUE047263T2 true HUE047263T2 (hu)	2020-04-28

Family

ID=45444677

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
HUE11804822A HUE033072T2 (hu)	2010-12-22	2011-12-21	Staphylococcus aureus antigének immunogén készítményei
HUE16193095A HUE047263T2 (hu)	2010-12-22	2011-12-21	Staphylococcus aureus antigének stabil immunogén készítményei

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
HUE11804822A HUE033072T2 (hu)	2010-12-22	2011-12-21	Staphylococcus aureus antigének immunogén készítményei

Country Status (18)

Country	Link
US (1)	US20130259896A1 (hu)
EP (2)	EP2654784B1 (hu)
JP (1)	JP6097478B2 (hu)
KR (2)	KR101808398B1 (hu)
CN (1)	CN103826656B (hu)
AU (1)	AU2011346535B2 (hu)
BR (1)	BR112013016153A2 (hu)
CA (1)	CA2819120C (hu)
DK (2)	DK3150222T3 (hu)
ES (2)	ES2769425T3 (hu)
HU (2)	HUE033072T2 (hu)
IL (1)	IL226793B (hu)
MX (1)	MX350170B (hu)
PL (2)	PL3150222T3 (hu)
PT (2)	PT3150222T (hu)
RU (1)	RU2570730C2 (hu)
SI (2)	SI3150222T1 (hu)
WO (1)	WO2012085872A2 (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2005287505A1 (en)	2004-09-22	2006-03-30	Biosynexus Incorporated	Staphylococcal immunogenic compositions
BRPI1011753B8 (pt)	2009-06-22	2021-05-25	Wyeth Llc	conjugados imunogênicos de polissacarídeo capsular de staphylococcus aureus de sorotipos 5 e 8, seu uso e composições que os compreendem
MX343111B (es)	2009-06-22	2016-10-25	Wyeth Llc	Composiciones inmunogenicas de antigenos de staphylococcus aureus.
RU2607024C2 (ru) *	2010-06-04	2017-01-10	УАЙТ ЭлЭлСи	Вакцины streptococcus pneumoniae
WO2012170097A2 (en) *	2011-03-16	2012-12-13	Regents Of The University Of Minnesota	Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus
GB201310008D0 (en) *	2013-06-05	2013-07-17	Glaxosmithkline Biolog Sa	Immunogenic composition for use in therapy
EP3076998A1 (en) *	2013-12-04	2016-10-12	Glycovaxyn AG	Prevention of staphylococcus aureus infections by glycoprotein vaccines synthesized in escherichia coli
IL310015B1 (en) *	2013-12-31	2025-10-01	Access To Advanced Health Inst	Single vial formulation
CA2942122A1 (en) *	2014-04-10	2015-10-15	Asit Biotech S.A.	Hsp-free allergen preparation
CN110996992A (zh) *	2017-08-16	2020-04-10	默沙东公司	肺炎球菌缀合物疫苗制剂
GB201802339D0 (en)	2018-02-13	2018-03-28	Glaxosmithkline Biologicals Sa	Immunogenic composition
KR102649069B1 (ko)	2018-05-31	2024-03-19	주식회사 엑소코바이오	줄기세포 유래의 엑소좀을 유효성분으로 포함하는 안면 홍조 개선용 조성물
WO2020027466A1 (ko)	2018-07-28	2020-02-06	주식회사 엑소코바이오	엑소좀의 동결건조 방법
KR102163806B1 (ko)	2018-07-30	2020-10-07	주식회사 엑소코바이오	줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물
IL294461A (en) *	2020-01-13	2022-09-01	Aptevo Res & Development Llc	Methods and compositions for preventing adsorption of therapeutic proteins to drug delivery system components

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4902506A (en)	1983-07-05	1990-02-20	The University Of Rochester	Immunogenic conjugates
US4673574A (en)	1981-08-31	1987-06-16	Anderson Porter W	Immunogenic conjugates
US4708871A (en)	1983-03-08	1987-11-24	Commonwealth Serum Laboratories Commission	Antigenically active amino acid sequences
SE8405493D0 (sv)	1984-11-01	1984-11-01	Bror Morein	Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5078996A (en)	1985-08-16	1992-01-07	Immunex Corporation	Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en)	1987-05-29	1991-10-15	Cambridge Biotech Corporation	Saponin adjuvant
US4912094B1 (en)	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
HU212924B (en)	1989-05-25	1996-12-30	Chiron Corp	Adjuvant formulation comprising a submicron oil droplet emulsion
IT1253009B (it)	1991-12-31	1995-07-10	Sclavo Ricerca S R L	Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
US5571515A (en)	1994-04-18	1996-11-05	The Wistar Institute Of Anatomy & Biology	Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en)	1994-07-15	2001-03-27	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
US6008341A (en)	1994-08-22	1999-12-28	The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin	S. aureus fibrinogen binding protein gene
BE1008978A5 (fr)	1994-12-27	1996-10-01	Solvay	Adjuvants pour vaccins.
WO1997014800A1 (en)	1995-10-16	1997-04-24	Smithkline Beecham Plc	Novel saliva binding protein
GB9622159D0 (en)	1996-10-24	1996-12-18	Solvay Sociutu Anonyme	Polyanionic polymers as adjuvants for mucosal immunization
GB9622660D0 (en)	1996-10-31	1997-01-08	Biocine Spa	Immunogenic detoxified mutant toxin
US6113918A (en)	1997-05-08	2000-09-05	Ribi Immunochem Research, Inc.	Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6680195B1 (en)	1997-11-26	2004-01-20	Inhibitex, Inc.	Extracellular matrix-binding proteins from staphylococcus aureus
EP1034277B1 (en)	1997-11-26	2012-06-27	Inhibitex, Inc.	Extracellular matrix-binding proteins from Staphylococcus aureus
WO2000012131A1 (en) *	1998-08-31	2000-03-09	Inhibitex, Inc.	Multicomponent vaccines
US6936258B1 (en)	1999-03-19	2005-08-30	Nabi Biopharmaceuticals	Staphylococcus antigen and vaccine
US7115730B1 (en)	1999-04-27	2006-10-03	Chiron Srl	Immunogenic detoxified mutant E. coli LT-A-toxin
US7384640B1 (en)	1999-09-30	2008-06-10	Wyeth Holdings Corporation	Mutant cholera holotoxin as an adjuvant
HU228264B1 (en)	2000-06-08	2013-02-28	Intercell Ag	Immunostimulatory oligodeoxynucleotides
AT410635B (de)	2000-10-18	2003-06-25	Cistem Biotechnologies Gmbh	Vakzin-zusammensetzung
IL159210A0 (en)	2001-06-07	2004-06-01	Wyeth Corp	Mutant forms of cholera holotoxin as an adjuvant
JP2005508143A (ja)	2001-06-07	2005-03-31	ワイス・ホールデイングス・コーポレーシヨン	アジュバントとしてのコレラホロトキシンの突然変異形
WO2002102829A2 (en)	2001-06-15	2002-12-27	Inhibitex, Inc.	Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
GB0118249D0 (en) *	2001-07-26	2001-09-19	Chiron Spa	Histidine vaccines
EP1601381A2 (en)	2003-03-07	2005-12-07	Wyeth Holdings Corporation	Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
WO2004083251A2 (en)	2003-03-17	2004-09-30	Wyeth Holdings Corporation	Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
GB0323103D0 (en)	2003-10-02	2003-11-05	Chiron Srl	De-acetylated saccharides
AU2005287505A1 (en) *	2004-09-22	2006-03-30	Biosynexus Incorporated	Staphylococcal immunogenic compositions
GB0606416D0 (en) *	2006-03-30	2006-05-10	Glaxosmithkline Biolog Sa	Immunogenic composition
AR060187A1 (es) *	2006-03-30	2008-05-28	Glaxosmithkline Biolog Sa	Composicion inmunogenica
EA015833B1 (ru) *	2006-03-30	2011-12-30	Глаксосмитклайн Байолоджикалс С.А.	Иммуногенная композиция
WO2007127668A2 (en)	2006-04-26	2007-11-08	Wyeth	Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
TWI417113B (zh) *	2006-11-07	2013-12-01	Acambis Inc	以凍乾法穩定疫苗
JP5689687B2 (ja)	2008-03-05	2015-03-25	サノフィ・パスツールＳａｎｏｆｉｐａｓｔｅｕｒ	アジュバント含有ワクチン組成物の安定化方法
MX343111B (es) *	2009-06-22	2016-10-25	Wyeth Llc	Composiciones inmunogenicas de antigenos de staphylococcus aureus.

2011
- 2011-12-21 CA CA2819120A patent/CA2819120C/en active Active
- 2011-12-21 SI SI201131825T patent/SI3150222T1/sl unknown
- 2011-12-21 CN CN201180068105.5A patent/CN103826656B/zh not_active Expired - Fee Related
- 2011-12-21 AU AU2011346535A patent/AU2011346535B2/en not_active Ceased
- 2011-12-21 PL PL16193095T patent/PL3150222T3/pl unknown
- 2011-12-21 MX MX2013006960A patent/MX350170B/es active IP Right Grant
- 2011-12-21 ES ES16193095T patent/ES2769425T3/es active Active
- 2011-12-21 EP EP11804822.2A patent/EP2654784B1/en active Active
- 2011-12-21 US US13/993,887 patent/US20130259896A1/en not_active Abandoned
- 2011-12-21 DK DK16193095.3T patent/DK3150222T3/da active
- 2011-12-21 ES ES11804822.2T patent/ES2614815T3/es active Active
- 2011-12-21 RU RU2013128277/15A patent/RU2570730C2/ru active IP Right Revival
- 2011-12-21 KR KR1020157031951A patent/KR101808398B1/ko not_active Expired - Fee Related
- 2011-12-21 DK DK11804822.2T patent/DK2654784T3/en active
- 2011-12-21 EP EP16193095.3A patent/EP3150222B1/en active Active
- 2011-12-21 HU HUE11804822A patent/HUE033072T2/hu unknown
- 2011-12-21 WO PCT/IB2011/055883 patent/WO2012085872A2/en not_active Ceased
- 2011-12-21 PT PT161930953T patent/PT3150222T/pt unknown
- 2011-12-21 KR KR1020137018851A patent/KR20130114210A/ko not_active Ceased
- 2011-12-21 PT PT118048222T patent/PT2654784T/pt unknown
- 2011-12-21 BR BR112013016153A patent/BR112013016153A2/pt not_active Application Discontinuation
- 2011-12-21 HU HUE16193095A patent/HUE047263T2/hu unknown
- 2011-12-21 SI SI201131064A patent/SI2654784T1/sl unknown
- 2011-12-21 PL PL11804822T patent/PL2654784T3/pl unknown
- 2011-12-22 JP JP2011280781A patent/JP6097478B2/ja not_active Expired - Fee Related
2013
- 2013-06-06 IL IL226793A patent/IL226793B/en active IP Right Grant

Also Published As

Publication number	Publication date
MX350170B (es)	2017-08-28
US20130259896A1 (en)	2013-10-03
ES2614815T3 (es)	2017-06-02
PT2654784T (pt)	2017-02-13
MX2013006960A (es)	2013-07-15
CA2819120C (en)	2016-07-05
WO2012085872A2 (en)	2012-06-28
JP6097478B2 (ja)	2017-03-15
HK1197370A1 (en)	2015-01-16
SI2654784T1 (sl)	2017-01-31
KR101808398B1 (ko)	2017-12-12
CA2819120A1 (en)	2012-06-28
AU2011346535A1 (en)	2013-06-13
SI3150222T1 (sl)	2020-02-28
WO2012085872A3 (en)	2012-08-30
PT3150222T (pt)	2020-02-03
CN103826656B (zh)	2015-08-26
RU2570730C2 (ru)	2015-12-10
DK3150222T3 (da)	2020-01-27
EP3150222B1 (en)	2019-11-27
CN103826656A (zh)	2014-05-28
AU2011346535B2 (en)	2015-09-24
HUE033072T2 (hu)	2017-11-28
RU2013128277A (ru)	2015-01-27
JP2012136518A (ja)	2012-07-19
PL2654784T3 (pl)	2017-08-31
PL3150222T3 (pl)	2020-05-18
BR112013016153A2 (pt)	2017-07-11
IL226793B (en)	2019-02-28
EP2654784A2 (en)	2013-10-30
DK2654784T3 (en)	2017-02-13
EP3150222A1 (en)	2017-04-05
KR20150129071A (ko)	2015-11-18
EP2654784B1 (en)	2016-12-07
ES2769425T3 (es)	2020-06-25
KR20130114210A (ko)	2013-10-16

Publication	Publication Date	Title
IL217084A0 (en)	2012-02-29	Immunogenic compositions of staphylococcus aureus antigens
IL226793B (en)	2019-02-28	Stable immunogenic compositions of staphylococcus aureus antigens
ZA202002470B (en)	2022-12-21	Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
IL231104A0 (en)	2014-04-30	Helper assemblies of antigens for Staphylococcus aureus
EP2549993A4 (en)	2014-08-06	ANTIMICROBIAL COMPOSITIONS
ZA201403788B (en)	2016-05-25	Stable pesticidal compositions
ZA201300073B (en)	2014-03-26	Compositions comprising optical benefit agents
AP2013006786A0 (en)	2013-04-30	Pesticidal compositions
AP2013006769A0 (en)	2013-03-31	Pesticidal compositions
BR112013017664A2 (pt)	2018-09-18	composições de pó de cacau
GB201015132D0 (en)	2010-10-27	Vaccine composition
IL238328A0 (en)	2015-06-30	Stable preparations that include peracetic acid
PL2768936T3 (pl)	2017-08-31	Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
EP2531026A4 (en)	2013-09-25	ANTIMICROBIAL FORMULATIONS ON POLYSACCHARID BASE
EP2605654A4 (en)	2014-01-22	ANTIMICROBIAL COMPOSITIONS
PL2407155T3 (pl)	2013-05-31	Formulacje inekalcytolu
ZA201301908B (en)	2019-08-28	Immunogenic compositions
GB201010944D0 (en)	2010-08-11	Antimicrobial compositions
GB201003799D0 (en)	2010-04-21	Antimicrobial compositions
GB201013150D0 (en)	2010-09-22	Antimicrobial compositions
GB201002594D0 (en)	2010-03-31	Antimicrobial compositions
GB201111128D0 (en)	2011-08-10	Antimicrobial compositions
AU2012900227A0 (en)	2012-02-09	Compositions of nimorazole
GB201005587D0 (en)	2010-05-19	Novel formulations